MX2022012189A - Composiciones que comprenden una variante del polipéptido cas12i2 y usos de las mismas. - Google Patents

Composiciones que comprenden una variante del polipéptido cas12i2 y usos de las mismas.

Info

Publication number
MX2022012189A
MX2022012189A MX2022012189A MX2022012189A MX2022012189A MX 2022012189 A MX2022012189 A MX 2022012189A MX 2022012189 A MX2022012189 A MX 2022012189A MX 2022012189 A MX2022012189 A MX 2022012189A MX 2022012189 A MX2022012189 A MX 2022012189A
Authority
MX
Mexico
Prior art keywords
cas12i2
variant
polypeptides
compositions
variant polypeptide
Prior art date
Application number
MX2022012189A
Other languages
English (en)
Inventor
David A Scott
Shaorong Chong
Brendan Jay Hilbert
Quinton Norman Wessells
Noah Michael Jakimo
Roy Ziblat
Jason Michael Carte
Tia Marie Ditommaso
Jeffrey Raymond Haswell
Anthony James Garrity
Colin Alexander Mcgaw
Derek Michael Cerchione
Original Assignee
Arbor Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Biotechnologies Inc filed Critical Arbor Biotechnologies Inc
Publication of MX2022012189A publication Critical patent/MX2022012189A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La presente invención se refiere a variantes del polipéptido Cas12i2, métodos para producir las variantes del polipéptido Cas12i2, procesos para caracterizar las variantes del polipéptido Cas12i2, células que comprenden las variantes del polipéptido Cas12i2 y métodos para utilizar las variantes del polipéptido Cas12i2. La invención se refiere además a complejos que comprenden las variantes del polipéptido Cas12i2, métodos para producir los complejos, procesos para caracterizar los complejos, células que comprenden los complejos y métodos para utilizar de los complejos.
MX2022012189A 2020-03-31 2021-03-31 Composiciones que comprenden una variante del polipéptido cas12i2 y usos de las mismas. MX2022012189A (es)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US202063003090P 2020-03-31 2020-03-31
US202063002999P 2020-03-31 2020-03-31
US202063003064P 2020-03-31 2020-03-31
US202063012007P 2020-04-17 2020-04-17
US202063026562P 2020-05-18 2020-05-18
US202063026606P 2020-05-18 2020-05-18
US202063026523P 2020-05-18 2020-05-18
US202063026277P 2020-05-18 2020-05-18
US202063063831P 2020-08-10 2020-08-10
US202063063819P 2020-08-10 2020-08-10
US202063063859P 2020-08-10 2020-08-10
US202063063879P 2020-08-10 2020-08-10
US202063085792P 2020-09-30 2020-09-30
US202063085752P 2020-09-30 2020-09-30
US202063085862P 2020-09-30 2020-09-30
US202063085895P 2020-09-30 2020-09-30
US202163147850P 2021-02-10 2021-02-10
US202163147968P 2021-02-10 2021-02-10
PCT/US2021/025257 WO2021202800A1 (en) 2020-03-31 2021-03-31 Compositions comprising a cas12i2 variant polypeptide and uses thereof

Publications (1)

Publication Number Publication Date
MX2022012189A true MX2022012189A (es) 2023-01-05

Family

ID=75640000

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022012189A MX2022012189A (es) 2020-03-31 2021-03-31 Composiciones que comprenden una variante del polipéptido cas12i2 y usos de las mismas.

Country Status (12)

Country Link
US (1) US20230332119A1 (es)
EP (1) EP4127154A1 (es)
JP (1) JP2023520504A (es)
KR (1) KR20230009379A (es)
CN (1) CN115698278A (es)
AU (1) AU2021249119A1 (es)
BR (1) BR112022019713A2 (es)
CA (1) CA3177749A1 (es)
CO (1) CO2022015170A2 (es)
IL (1) IL296791A (es)
MX (1) MX2022012189A (es)
WO (1) WO2021202800A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021243267A2 (en) * 2020-05-29 2021-12-02 Arbor Biotechnologies, Inc. Compositions comprising a cas12i2 polypeptide and uses thereof
WO2022094329A1 (en) * 2020-10-30 2022-05-05 Arbor Biotechnologies, Inc. Compositions comprising an rna guide targeting pdcd1 and uses thereof
US20240102007A1 (en) 2021-06-01 2024-03-28 Arbor Biotechnologies, Inc. Gene editing systems comprising a crispr nuclease and uses thereof
EP4347831A2 (en) 2021-06-04 2024-04-10 Arbor Biotechnologies, Inc. Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereof
EP4347833A2 (en) 2021-06-04 2024-04-10 Arbor Biotechnologies, Inc. Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereof
WO2022256655A2 (en) 2021-06-04 2022-12-08 Arbor Biotechnologies, Inc. Gene editing systems comprising an rna guide targeting lactate dehydrogenase a (ldha) and uses thereof
WO2023018856A1 (en) 2021-08-11 2023-02-16 Arbor Biotechnologies, Inc. Gene editing systems comprising an rna guide targeting polypyrimidine tract binding protein 1 (ptbp1) and uses thereof
KR20240052763A (ko) 2021-08-11 2024-04-23 아버 바이오테크놀로지스, 인크. 스타스민 2 (stmn2)를 표적화하는 rna 가이드를 포함하는 유전자 편집 시스템 및 이의 용도
WO2023034475A1 (en) 2021-09-01 2023-03-09 Arbor Biotechnologies, Inc. Cells modified by a cas12i polypeptide
WO2023081377A2 (en) * 2021-11-05 2023-05-11 Arbor Biotechnologies, Inc. Compositions comprising an rna guide targeting ciita and uses thereof
WO2023122433A1 (en) 2021-12-22 2023-06-29 Arbor Biotechnologies, Inc. Gene editing systems targeting hydroxyacid oxidase 1 (hao1) and lactate dehydrogenase a (ldha)
WO2023138685A1 (en) * 2022-01-24 2023-07-27 Huidagene Therapeutics Co., Ltd. Novel crispr-cas12i systems and uses thereof
WO2023208003A1 (en) * 2022-04-25 2023-11-02 Huidagene Therapeutics Co., Ltd. Novel crispr-cas12i systems and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201707569YA (en) 2012-12-12 2017-10-30 Broad Inst Inc Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications
DK3066201T3 (en) 2013-11-07 2018-06-06 Editas Medicine Inc CRISPR-RELATED PROCEDURES AND COMPOSITIONS WITH LEADING GRADES
DK3765615T3 (da) * 2018-03-14 2023-08-21 Arbor Biotechnologies Inc Nye enzymer og systemer til målretning af crispr dna

Also Published As

Publication number Publication date
US20230332119A1 (en) 2023-10-19
EP4127154A1 (en) 2023-02-08
WO2021202800A1 (en) 2021-10-07
CO2022015170A2 (es) 2022-11-08
AU2021249119A1 (en) 2022-10-20
JP2023520504A (ja) 2023-05-17
CN115698278A (zh) 2023-02-03
BR112022019713A2 (pt) 2022-12-20
IL296791A (en) 2022-11-01
KR20230009379A (ko) 2023-01-17
CA3177749A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
MX2022012189A (es) Composiciones que comprenden una variante del polipéptido cas12i2 y usos de las mismas.
MX2021005254A (es) Produccion recombinante de una preparacion de peptido de colageno y uso de la misma.
WO2020084305A9 (en) Bicyclic peptide ligands and uses thereof
EP3708660A3 (en) Polypeptides
NZ734670A (en) Cells for producing recombinant iduronate-2-sulfatase
SI1948789T1 (sl) Postopek za pridobivanje permanentnih humanih celičnih linij
MX2018016114A (es) Una novedosa fructosa-6-fosfato-3-epimerasa termoestable y un procedimiento para producir alulosa mediante el uso de la misma.
MX2021010827A (es) Materiales funcionales de origen vegetal.
MX2019013419A (es) Compuestos plaguicidas biciclicos.
MX2023005421A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
MX2021012871A (es) Generacion de polipeptidos derivados de anticuerpos mediante intercambio de cadenas polipeptidicas.
WO2018170150A3 (en) Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins
MX2023001595A (es) Proteinas de fusion que comprenden proteinas de leche y composiciones de las mismas.
MX2021000328A (es) Enzimas de variantes de galactosa oxidasa modificadas geneticamente.
SG10201805039UA (en) Protease resistant peptides
MX2022012541A (es) Inmunoconjugados.
MX2021011976A (es) Composiciones de control de artropodos.
AU2019350356A8 (en) Arginase1 polypeptides
NZ744289A (en) Composition containing amino acids
MX2023009399A (es) Composiciones que comprenden un polipéptido cas12i4 variante y usos de las mismas.
MX2021015301A (es) Métodos de cultivo celular y composiciones para la producción de anticuerpos.
ZA202204993B (en) Expression of nitrogenase polypeptides in plant cells
WO2023039534A3 (en) Compositions comprising a cas12i polypeptide and uses thereof
ZA202107143B (en) Expression of nitrogenase polypeptides in plant cells
WO2023039472A3 (en) Compositions comprising a crispr nuclease and uses thereof